Is Continuous Non-Invasive Monitoring Accurate When Used on the Lower Extremity: Finger Vs Toe?

February 4, 2025 updated by: Christopher Baker, Riverside University Health System Medical Center

Is Continuous Non-Invasive Monitoring Accurate When Used on the Lower Extremity?: a Pilot Study

The goal of this observational study is to assess the validity of a continuous non-invasive blood pressure monitoring device, Acumen IQ cuff (Edwards Lifesciences LLC, Irvine, CA), when used on the toe in healthy volunteers. The main questions it aims to answer is:

• Can a continuous non-invasive blood pressure monitoring device accurately measure hemodynamic parameters when placed on a toe as compared to the finger in a healthy volunteer?

Secondary Outcomes:

  • What are the effects of length and circumference of the middle phalanx of the 2nd toe on the accuracy of the Acumen IQ cuff (Edwards Lifesciences LLC, Irvine, CA) measurements compared to the measurements taken from the finger?
  • What are the effects of a Valsalva maneuver on the measurements taken from the Acumen IQ cuff (Edwards Lifesciences LLC, Irvine, CA) on a toe compared to the Acumen IQ cuff (Edwards Lifesciences LLC, Irvine, CA) placed on the finger.

Participants will:

  • Have blood pressures taken using an automatic blood pressure cuff (both arms and both calves)
  • Have a continuous non-invasive blood pressure monitoring sensor placed on their finger and toe simultaneously for 10 minutes
  • Be asked to valsalva briefly to induce a change in blood pressure to be observed by the dual sensors

Study Overview

Detailed Description

For each volunteer the investigators will measure the length from the proximal interphalangeal (PIP) joint to the distal interphalangeal (DIP) joint of the 2nd toe as well as the circumference at the center of the middle phalanx of the 2nd toe which the Acumen IQ cuff (Edwards Lifesciences LLC, Irvine, CA) will be placed on. Data including the hemodynamic measurements from the toe and finger cuffs will be collected. Laterality of cuff placement on finger and toes will be noted. Age, gender, height, and weight of the volunteers will be recorded.

During the trials the monitors will not be visible once necessary adjustments have been made and before data collection has begun. The two data sets from each sensor (finger and toe) will be linked together at the time of data collection. The investigators will not be able to tell which volunteer the data belongs to when analyzing the data.

Prior to the placing the Acumen IQ cuff (Edwards Lifesciences LLC, Irvine, CA), baseline blood pressures will be taken at the start of the study from each extremity using an automatic blood pressure cuff.

The healthy volunteer will have one Acumen IQ cuff (Edwards Lifesciences LLC, Irvine, CA) placed on the 2nd toe and one Acumen IQ cuff (Edwards Lifesciences LLC, Irvine, CA) place on the index finger. The study will be performed in a break room with minimal external stimulus. The volunteer will be asked to lie supine for approximately 3 minutes until the sensors have calibrated. They will remain in the supine position for another 5 minutes for data collection. An automatic blood pressure cuff on the contralateral lower extremity to the Acumen IQ cuff (Edwards Lifesciences LLC, Irvine, CA) will measure blood pressures at 0, 2.5, and 5 minutes. They will then be asked to perform a Valsalva maneuver at their own discretion for no longer than 5 seconds. The research protocol will be performed by the research coordinator on staff. Data collection occurs automatically every 20 seconds, but manual recording of data will be performed. The two continuous monitoring devices will be synced at the beginning of the study by simultaneously inputting a flagged event from which the start time will be inferred during data analysis.

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Moreno Valley, California, United States, 92555
        • Riverside University Health System Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population will consistent of a convenience sample of available healthy volunteer medical students or residents.

Description

Inclusion Criteria:

  • 18 years or older
  • Medical student or resident

Exclusion Criteria:

  • Medical history of Raynaud's or peripheral vascular disease
  • Allergy to adhesive

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy volunteers
Healthy volunteers consisting of medical students and residents at our institution.
A continuous non-invasive blood pressure monitoring cuff will be placed on the volunteers index finger (as intended) and 2nd toe (primary outcome).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison between output from the continuous non-invasive blood pressure cuff placed on the volunteers index finger compared to the output from the continuous non-invasive blood pressure cuff placed on the volunteers 2nd toe.
Time Frame: Continuous non-invasive blood pressure measurements will be collected for 10 minutes
The continuous non-invasive blood pressure cuff measures mean arterial pressure which will be compared between the index finger and 2nd toe of the same volunteer.
Continuous non-invasive blood pressure measurements will be collected for 10 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effects of length and circumference of the middle phalanx of the 2nd toe on the accuracy of the continuous non-invasive blood pressure cuff measurements compared to the measurements taken from the index finger.
Time Frame: Continuous non-invasive blood pressure measurements will be collected for 10 minutes.
To compare the measurements from the index finger cuff to the 2nd toe cuff based on the length and circumference of the middle phalanx of the 2nd toe.
Continuous non-invasive blood pressure measurements will be collected for 10 minutes.
Validity of the continuous non-invasive blood pressure monitoring cuff on the toe compared to automatic blood pressure cuff measurements on the contralateral lower extremity.
Time Frame: Continuous non-invasive blood pressure measurements will be collected for 10 minutes
To compare and assess the validity of the continuous non-invasive blood pressure monitoring cuff on the 2nd toe compared to measurements taken via an automatic blood pressure cuff from the contralateral lower extremity.
Continuous non-invasive blood pressure measurements will be collected for 10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 29, 2025

Primary Completion (Actual)

February 1, 2025

Study Completion (Actual)

February 1, 2025

Study Registration Dates

First Submitted

January 28, 2025

First Submitted That Met QC Criteria

January 28, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 4, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2219626-3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No plan is in place to share IPD at this time.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Pressure

Clinical Trials on Continuous non-invasive blood pressure monitoring

Subscribe